Date |
Time |
Source |
Heading |
11/21/2023 | 11:06 | DJN | Roche's Genentech, Nvidia Team Up to Accelerate Drug.. |
11/07/2023 | 17:14 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
10/31/2023 | 02:26 | DJN | Roche Says Late-Stage Muscular Dystrophy Trial Didn't Meet.. |
10/27/2023 | 01:40 | DJN | Roche Gets FDA Approval for Vabysmo as Retinal Vein.. |
10/23/2023 | 15:41 | DJN | Trending: Roche to Buy Telavant From Roivant and Pfizer |
10/23/2023 | 04:16 | DJN | Roche to Buy Telavant From Roivant, Pfizer in Deal Worth Up.. |
10/23/2023 | 01:50 | DJN | Roche to Buy Telavant From Roivant Sciences and Pfizer in.. |
10/19/2023 | 05:55 | DJN | Roche Shares Fall on Lower Sales Due to Currency Hit |
10/19/2023 | 01:48 | DJN | Roche Backs Guidance After Sales Fall |
10/18/2023 | 02:14 | DJN | Roche Lung Cancer Drug Reduced Risk of Recurrence, Death in.. |
10/18/2023 | 01:54 | DJN | Roche's Elecsys IL-6 Test Approved for Diagnosis of Neonatal.. |
9/29/2023 | 08:15 | DJN | AbbVie: Phase 3 Venetoclax/Dexamethasone Study Falls Short.. |
9/27/2023 | 07:59 | DJN | Ionis, Roche Set New Pact Targeting Alzheimer's,.. |
9/20/2023 | 08:45 | IHNW | Pathways to Progress: How Orphan Drug Designation Sparks.. |
9/06/2023 | 01:52 | DJN | Roche's Blood Disorder Drug Crovalimab Takes Step Toward FDA.. |
9/01/2023 | 02:04 | DJN | Roche Lung Cancer Drug Shows Promise in Phase 3 Trial |
8/29/2023 | 05:51 | DJN | Roche's Tecentriq Intravenous Cancer Therapy Gets UK.. |
8/29/2023 | 01:52 | DJN | Roche Says EU Has Approved Evrysdi for Babies Under Two.. |
8/23/2023 | 05:36 | DJN | Roche Shares Climb After Interim Data Shows Survival Gain in.. |
8/23/2023 | 02:56 | DJN | Roche Says Data From Lung Cancer Trial Was Inadvertently.. |
7/27/2023 | 01:52 | DJN | Roche Backs 2023 Outlook Despite Weaker Covid-19 Demand.. |
7/21/2023 | 10:25 | DJN | Roche Gets EU Recommendation for Evrysdi for Babies Under.. |
7/14/2023 | 07:51 | IHMARKETNEWS | Friday’s Wall Street Highlights: JPMorgan Chase, Coinbase,.. |
6/16/2023 | 01:44 | DJN | Roche Gets FDA Approval for Columvi Lymphoma Treatment |
4/26/2023 | 01:53 | DJN | Roche 1Q Sales Dragged by Diagnostics Division; Backs 2023.. |
4/17/2023 | 01:44 | DJN | Roche's Tecentriq Shows Further Good Survival Rates as.. |
3/10/2023 | 01:57 | DJN | FDA Committee Backs Roche's Lymphoma Treatment |
2/03/2023 | 02:24 | DJN | Trending: Roche Guides for 2023 Sales, Earnings Decline on.. |
2/02/2023 | 02:28 | DJN | Roche 2022 Sales Grew, But Expects 2023 Decline on Covid-19.. |
2/02/2023 | 02:02 | DJN | Roche 2022 Sales Grew, But Expects 2023 Decline on Covid-19.. |
1/09/2023 | 13:40 | DJN | Sonnet BioTherapeutics Shares Up 8% on Roche Collaboration |
12/23/2022 | 12:31 | DJN | Roche's Lunsumio Lymphoma Treatment Gets FDA Approval |
12/12/2022 | 02:26 | DJN | Roche's Phase 3 Data Show Lymphoma Treatment Can Reduce.. |
12/09/2022 | 09:41 | DJN | Correction to Biogen Actemra Biosimilar Article |
12/09/2022 | 08:20 | DJN | Biogen: FDA Accepts Application for Actemra Biosimilar |
12/07/2022 | 07:44 | DJN | Replimune, Roche to Develop RP3 in Colorectal Cancer,.. |